Fermentation-derived milk casein peptides attenuate colonic nuclear factor-kappa B signaling and associated neuroinflammatory responses in dextran sodium sulfate-induced colitis mice
Received: Oct 13, 2026; Revised: Nov 04, 2026; Accepted: Nov 16, 2026
Published Online: Nov 18, 2026
Abstract
Fermentation of milk proteins releases bioactive peptides with potential health benefits, yet the specific peptides responsible for the anti-inflammatory activity of fermented casein remain largely unidentified. Therefore, this study aimed to identify anti-inflammatory peptides from sodium caseinate fermented with Lactobacillus gasseri KML39 (FSC) and to evaluate their preventive effects against colitis and colitis-associated brain alterations. FSC was fractionated, and four peptides (P1–P4) were identified from the antioxidant-active fractions by MALDI-TOF-MS/MS. Molecular docking against the TLR4/MD-2 complex was performed as an initial screening step, and all four peptides occupied the predicted binding pocket with comparable binding energies. In lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages, P1 and P4 consistently suppressed nitric oxide (NO) production and the mRNA expression of TLR4, COX-2, iNOS, IL-1β, and IL-6, whereas P2 and P3 showed more limited effects. Molecular dynamics simulations further showed that P1 and P4 formed more conformationally stable complexes with TLR4/MD-2 than P2 and P3, providing structural support for their selection for invivo evaluation and suggesting TLR4/MD-2 as a computationally predicted target. In a dextran sodium sulfate (DSS)-induced colitis mouse model, oral pretreatment with P1 and P4 attenuated histopathological damage, suppressed NF-κB-mediated inflammatory signaling in colonic tissues, and reduced serum TNF-α levels. In the brain, both peptides reduced the pro-apoptotic marker BAX and restored the Bcl-2/BAX ratio. Notably, P4 additionally preserved intestinal barrier integrity and attenuated the colitis-associated increase in serum corticosterone, loss of blood–brain barrier Claudin-5, neuroinflammatory responses, and reduction of Bcl-2 in the brain, whereas P1 showed a narrower range of activity. Colonic inflammatory parameters were significantly correlated with serum and brain alterations. However, direct engagement of TLR4/MD-2 was not experimentally verified, the invivo design assessed preventive rather than therapeutic efficacy, and the gut–brain associations were correlational. These results suggest that P4 (VLSRYPSYG), which exhibited the broadest protective profile among the identified peptides, has potential as a fermentation-derived food peptide for the preventive dietary management of intestinal inflammation and its associated neuroinflammatory consequences.
Metrics
QR Code of this Article:
Related Articles
Rabbit meat extract alleviates diet-induced obesity via adipose browning with identification of a novel bioactive peptide
J Anim Sci Technol 2026 [published online ahead of print: Jul 31, 2026]
Protective effects of enzymatically digested velvet antler polypeptides on mitochondria in primary astrocytes
J Anim Sci Technol 2025;67(1):164-178.
Complete genome sequence of candidate probiotic
J Anim Sci Technol 2024;66(4):859-862.
